antithrombotic medications

High-Alert Medications
High-Alert MedicationsHigh-alert drugs pose a significant threat to patient safety. There are safeguards that pharmacists should put in place to reduce the risk.
ACC: NVAF patients at high risk for stroke may be undertreatedMany nonvalvular atrial fibrillation (NVAF) patients at high risk for stroke may be undertreated, according to poster presentation sessions at the American College of Cardiology (ACC) 64th Annual Scientific Session in San Diego, Calif.
Post-MI NSAID/anticoag combo may increase risk of CV bleeding eventsAmong patients receiving antithrombotic therapy (to prevent the formation of blood clots) after a heart attack, the use of nonsteroidal anti-inflammatory drugs (NSAIDs) was associated with an increased risk of bleeding and events such as heart attack, stroke or cardiovascular death, even after short-term treatment, according to a study in the February 24 issue of JAMA.
Web-based program aids clinicians in anticoagulation treatment
Web-based program aids clinicians in anticoagulation treatmentA new web-based program aims to help clinical pharmacists and other healthcare professionals achieve the best possible outcomes for their patients on antithrombotic medications.